Sehgal, K., Bulumulle, A., Brody, H., Gill, R. R., Macherla, S., Qilleri, A., . . . Rangachari, D. (2021). Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer. Clin Lung Cancer.
Citação norma ChicagoSehgal, Kartik, et al. "Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer." Clin Lung Cancer 2021.
Citação norma MLASehgal, Kartik, et al. "Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer." Clin Lung Cancer 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.